• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过分层错误发现率控制在癌症基因组中寻找共突变基因和候选癌症基因。

Finding co-mutated genes and candidate cancer genes in cancer genomes by stratified false discovery rate control.

作者信息

Wang Jing, Zhang Yang, Shen Xiaopei, Zhu Jing, Zhang Lin, Zou Jinfeng, Guo Zheng

机构信息

Bioinformatics Centre and Key Laboratory for NeuroInfomation of the Education Ministry of China, School of Life Science, University of Electronic Science and Technology of China, Chengdu 610054, China.

出版信息

Mol Biosyst. 2011 Apr;7(4):1158-66. doi: 10.1039/c0mb00211a. Epub 2011 Jan 28.

DOI:10.1039/c0mb00211a
PMID:21279201
Abstract

Finding candidate cancer genes playing causal roles in carcinogenesis is an important task in cancer research. The non-randomness of the co-mutation of genes in cancer samples can provide statistical evidence for these genes' involvement in carcinogenesis. It can also provide important information on the functional cooperation of gene mutations in cancer. However, due to the relatively small sample sizes used in current high-throughput somatic mutation screening studies and the extraordinary large-scale hypothesis tests, the statistical power of finding co-mutated gene pairs based on high-throughput somatic mutation data of cancer genomes is very low. Thus, we proposed a stratified FDR (False Discovery Rate) control approach, for identifying significantly co-mutated gene pairs according to the mutation frequency of genes. We then compared the identified co-mutated gene pairs separately by pre-selecting genes with higher mutation frequencies and by the stratified FDR control approach. Finally, we searched for pairs of pathways annotated with significantly more between-pathway co-mutated gene pairs to evaluate the functional roles of the identified co-mutated gene pairs. Based on two datasets of somatic mutations in cancer genomes, we demonstrated that, at a given FDR level, the power of finding co-mutated gene pairs could be increased by pre-selecting genes with higher mutation frequencies. However, many true co-mutation between genes with lower mutation rates will still be missed. By the stratified FDR control approach, many more co-mutated gene pairs could be found. Finally, the identified pathway pairs significantly overrepresented with between-pathway co-mutated gene pairs suggested that their co-dysregulations may play causal roles in carcinogenesis. The stratified FDR control strategy is efficient in identifying co-mutated gene pairs and the genes in the identified co-mutated gene pairs can be considered as candidate cancer genes because their non-random co-mutations in cancer genomes are highly unlikely to be attributable to chance.

摘要

寻找在致癌过程中起因果作用的候选癌症基因是癌症研究中的一项重要任务。癌症样本中基因共突变的非随机性可为这些基因参与致癌过程提供统计学证据。它还可以提供有关癌症中基因突变功能协作的重要信息。然而,由于当前高通量体细胞突变筛查研究中使用的样本量相对较小,以及大规模假设检验的规模极大,基于癌症基因组高通量体细胞突变数据寻找共突变基因对的统计功效非常低。因此,我们提出了一种分层错误发现率(False Discovery Rate,FDR)控制方法,用于根据基因的突变频率识别显著共突变的基因对。然后,我们分别通过预先选择具有较高突变频率的基因和分层FDR控制方法来比较识别出的共突变基因对。最后,我们搜索注释有显著更多通路间共突变基因对的通路对,以评估识别出的共突变基因对的功能作用。基于两个癌症基因组体细胞突变数据集,我们证明,在给定的FDR水平下,通过预先选择具有较高突变频率的基因,可以提高寻找共突变基因对的功效。然而,许多低突变率基因之间的真正共突变仍会被遗漏。通过分层FDR控制方法,可以发现更多的共突变基因对。最后,识别出的通路对中通路间共突变基因对显著富集,这表明它们的共同失调可能在致癌过程中起因果作用。分层FDR控制策略在识别共突变基因对方面是有效的,并且识别出的共突变基因对中的基因可被视为候选癌症基因,因为它们在癌症基因组中的非随机共突变极不可能是偶然造成的。

相似文献

1
Finding co-mutated genes and candidate cancer genes in cancer genomes by stratified false discovery rate control.通过分层错误发现率控制在癌症基因组中寻找共突变基因和候选癌症基因。
Mol Biosyst. 2011 Apr;7(4):1158-66. doi: 10.1039/c0mb00211a. Epub 2011 Jan 28.
2
Co-mutated pathways analysis highlights the coordination mechanism in glioblastoma multiforme.共突变途径分析突出胶质母细胞瘤多形性的协调机制。
Neoplasma. 2014;61(4):424-32. doi: 10.4149/neo_2014_052.
3
Algorithms for detecting significantly mutated pathways in cancer.用于检测癌症中显著突变通路的算法。
J Comput Biol. 2011 Mar;18(3):507-22. doi: 10.1089/cmb.2010.0265.
4
VarWalker: personalized mutation network analysis of putative cancer genes from next-generation sequencing data.VarWalker:基于下一代测序数据对假定癌症基因进行个性化突变网络分析
PLoS Comput Biol. 2014 Feb 6;10(2):e1003460. doi: 10.1371/journal.pcbi.1003460. eCollection 2014 Feb.
5
Identification of mutated core cancer modules by integrating somatic mutation, copy number variation, and gene expression data.通过整合体细胞突变、拷贝数变异和基因表达数据来鉴定核心癌症突变模块。
BMC Syst Biol. 2013;7 Suppl 2(Suppl 2):S4. doi: 10.1186/1752-0509-7-S2-S4. Epub 2013 Oct 14.
6
Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes.泛癌网络分析确定了跨通路和蛋白质复合物的罕见体细胞突变组合。
Nat Genet. 2015 Feb;47(2):106-14. doi: 10.1038/ng.3168. Epub 2014 Dec 15.
7
Cancer Gene Discovery by Network Analysis of Somatic Mutations Using the MUFFINN Server.使用MUFFINN服务器通过体细胞突变的网络分析发现癌症基因
Methods Mol Biol. 2019;1907:37-50. doi: 10.1007/978-1-4939-8967-6_3.
8
De novo discovery of mutated driver pathways in cancer.癌症中突变驱动途径的从头发现。
Genome Res. 2012 Feb;22(2):375-85. doi: 10.1101/gr.120477.111. Epub 2011 Jun 7.
9
MUFFINN: cancer gene discovery via network analysis of somatic mutation data.MUFFINN:通过体细胞突变数据的网络分析发现癌症基因
Genome Biol. 2016 Jun 23;17(1):129. doi: 10.1186/s13059-016-0989-x.
10
Systematic interpretation of comutated genes in large-scale cancer mutation profiles.系统解读大规模癌症突变图谱中的计算基因。
Mol Cancer Ther. 2010 Aug;9(8):2186-95. doi: 10.1158/1535-7163.MCT-10-0022. Epub 2010 Jul 27.

引用本文的文献

1
Cooperative genomic alteration network reveals molecular classification across 12 major cancer types.合作基因组改变网络揭示了12种主要癌症类型的分子分类。
Nucleic Acids Res. 2017 Jan 25;45(2):567-582. doi: 10.1093/nar/gkw1087. Epub 2016 Nov 29.
2
Chromatin accessibility contributes to simultaneous mutations of cancer genes.染色质可及性促成癌症基因的同时突变。
Sci Rep. 2016 Oct 20;6:35270. doi: 10.1038/srep35270.
3
Reproducible cancer biomarker discovery in SELDI-TOF MS using different pre-processing algorithms.基于 SELDI-TOF MS 的不同预处理算法的可重现性癌症生物标志物发现。
PLoS One. 2011;6(10):e26294. doi: 10.1371/journal.pone.0026294. Epub 2011 Oct 14.